Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma | Synapse

June 20, 2007Open Access

Ver artículo completo

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Robert A. KyleDartmouth College EREllen D. RemsteinMayo Clinic TTTerry M. TherneauMayo Clinic

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The risk of progression from smoldering multiple myeloma to symptomatic disease is related to the proportion of bone marrow plasma cells and the serum monoclonal protein level at diagnosis.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Kyle et al. (Wed,) studied this question.

synapsesocial.com/papers/69c9f16bd07d95773800da1a https://doi.org/https://doi.org/10.1056/nejmoa070389